Altın, C. Et Al. 2022. The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study). Archives of the Turkish Society of Cardiology , vol.50, no.8 , 568-575.

Altın, C., Okyay, K., Kış, M., Eren, H., Bekar, L., Doğan, Y., ... Aydın, G.(2022). The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study). Archives of the Turkish Society of Cardiology , vol.50, no.8, 568-575.

Altın, Cihan Et Al. "The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study)," Archives of the Turkish Society of Cardiology , vol.50, no.8, 568-575, 2022

Altın, Cihan Et Al. "The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study)." Archives of the Turkish Society of Cardiology , vol.50, no.8, pp.568-575, 2022

Altın, C. Et Al. (2022) . "The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study)." Archives of the Turkish Society of Cardiology , vol.50, no.8, pp.568-575.

@article{article, author={Cihan Altın Et Al. }, title={The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study)}, journal={Archives of the Turkish Society of Cardiology}, year=2022, pages={568-575} }